Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer - Poll - MDSpire

Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer

  • By

  • M Quinn Peters

  • Amber L Young

  • Jennifer E Stolarczuk

  • Madeline Glad

  • Erik Layton

  • Jennifer K Logue

  • Nana K Minkah

  • Helen Y Chu

  • Janet A Englund

  • D Noah Sather

  • Chetan Seshadri

  • Alisa Kachikis

  • Whitney E Harrington

  • September 29, 2025

  • 0 min

Share

Original Source(s)

Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer

  • by M Quinn Peters, Amber L Young, Jennifer E Stolarczuk, Madeline Glad, Erik Layton, Jennifer K Logue, Nana K Minkah, Helen Y Chu, Janet A Englund, D Noah Sather, Chetan Seshadri, Alisa Kachikis, Whitney E Harrington

  • September 29, 2025

Related Content

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

AAE Revises Dental Trauma Guidance

Recommendations outline splinting, replantation timing, imaging, and long-term surveillance strategies for permanent tooth injuries.

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update